Alle verbonden artikelen

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer.

Auteurs : Hamm A, Prenen H, Van Delm W, Di Matteo M, Wenes M, Delamarre E, Schmidt T, Weitz J, Sarmiento R, Dezi A, Gasparini G, Rothé F, Schmitz R, Dhoore A, Iserentant H, Hendlisz A, Mazzone M
Jaar : 2016
Journal : Gut
Volume : 65(6)
Pagina's : 990-1000

Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2.

Auteurs : Gebhart G, Flamen P, de Vries EG, Jhaveri K, Wimana Z
Jaar : 2016
Journal : J Nucl Med
Volume : 57 Suppl 1
Pagina's : 81S-8S

Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.

Auteurs : Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, Peccatori FA, Azim HA Jr
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 49
Pagina's : 65-76

Is it possible to improve communication around radiotherapy delivery: A randomized study to assess the efficacy of team training?

Auteurs : Liénard A, Delevallez F, Razavi D, Gibon AS, Libert Y, Delvaux N, Marchal S, Etienne AM, Bragard I, Reynaert C, Slachmuylder JL, Durieux JF, Farvacques C, Scalliet P, Van Houtte P, Coucke P, Merckaert I
Jaar : 2016
Journal : Radiother Oncol
Volume : 119
Pagina's : 361-67

Eribulin in the soft tissue sarcoma therapeutic landscape: little is good, then more is better

Auteurs : Awada A, Penel N, Kotecki N
Jaar : 2016
Journal : TCR
Volume : 5(6)
Pagina's : s1160-62

Threat posed by unproven drugs in medical oncology.

Auteurs : Pondé N, Ades F, de Azambuja E
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000064

Frequent incidence of BARD1 truncating mutations in germline DNA from triple negative breast cancer patients.

Auteurs : De Brakeleer S, De Grève J, Desmedt C, Joris S, Sotiriou C, Piccart-Gebhart M, Pauwels I, Teugels E
Jaar : 2016
Journal : Clin. Genet.
Volume : 89(3)
Pagina's : 336-40.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Auteurs : Phillips RS, Sung L, Amman RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA
Jaar : 2016
Journal : Br J Cancer
Volume : 114
Pagina's : 623-630

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience.

Auteurs : Metzger-Filho O, de Azambuja E, Procter M, Krieguer M, Smith I, Baselga J, Cameron D, Untch M, Jackisch C, Bell R, Gianni L, Goldhirsch A, Piccart-Gebhart M, Gelber Rd
Jaar : 2016
Journal : Breast Cancer Res Treat
Volume : 155
Pagina's : 127-32

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French So

Auteurs : Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Jaar : 2016
Journal : Ann Intensive Care
Volume : 6
Pagina's : 90

Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes.

Auteurs : Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjövall A, Brge Johannesen T, Moreau M, Liberale G, Gonçalves AF, Bento MJ, van de Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H
Jaar : 2016
Journal : Medicine (Baltimore)
Volume : 95(22)
Pagina's : e3812

Phosphoethanolamine and the danger of unproven drugs.

Auteurs : Pondé N, de Azambuja E, Ades F
Jaar : 2016
Journal : Ecancermedicalscience
Volume : 10
Pagina's : 681

Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.

Auteurs : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Jaar : 2016
Journal : Eur J Cancer
Volume : 56
Pagina's : 85-92

Innovative approach to older patients with malignant hemopathies.

Auteurs : Bron D, Soubeyran P, Fulop T
Jaar : 2016
Journal : Haematologica
Volume : 101
Pagina's : 893-5

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Auteurs : Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G, Lee SC, Mehta AO, Kim SB, Bachelot T, Goswami C, Deo S, Bose R, Wong A, Xu F, Yao B, Bryce R, Carey LA
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(12)
Pagina's : 1557-64

Moderne indications for endoscopic endonasal surgery

Auteurs : Lipski SM, Digonnet A, Dolhen P
Jaar : 2016
Journal : EMJ Oncology
Volume : -
Pagina's : -

(1, 3)-ß-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.

Auteurs : Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F
Jaar : 2016
Journal : Oncotarget
Volume : 7(16)
Pagina's : 21484-95

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.

Auteurs : Aspeslagh S, Awada A, S Matos-Pita A, Aftimos P, Bahleda R, Varga A, Soria JC
Jaar : 2016
Journal : Anticancer Drugs
Volume : 27
Pagina's : 1021-7

Phase 2 Study of Trabectedin in Patients With Hormone Receptor-Positive, HER-2-Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene.

Auteurs : Awada A, Cortés J, Martín M, Aftimos P, Oliveira M, López-Tarruella S, Espie M, Lardelli P, Extremera S, Fernández-García EM, Delaloge S
Jaar : 2016
Journal : Clin Breast Cancer
Volume : 16(5)
Pagina's : 364-71

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation.

Auteurs : Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A
Jaar : 2016
Journal : Ecancermedicalscience
Volume : 10
Pagina's : 691